| Price | 1,918.00on 20-09-2019 at 16:30:00 |
|---|---|
| Change | 5.50 0.29% |
| Buy | 1,917.00 |
| Sell | 1,915.50 |
| Buy / Sell SN. Shares | |
| Last Trade: | Buy 1,598 at 1,916.887p |
| Day's Volume: | 3,395,942 |
| Last Close: | 1,912.50p |
| Open: | 1,905.00p |
| ISIN: | GB0009223206 |
| Day's Range | 1,898.00p - 1,926.00p |
| 52wk Range: | 1,242.50p - 1,998.00p |
| Market Capitalisation: | £16,727m |
| VWAP: | 0.00p |
| Shares in Issue: | 876m |
Sector: Health Care and Related Services
Listed in: FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 Low Yield
Recent Trades History Smith & Nephew (SN.) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,598 | 1,916.887 | Ordinary | 18:45:04 - 20-Sep-19 |
| Buy* | 2,400 | 1,918.00 | Ordinary Delayed publication | 17:38:38 - 20-Sep-19 |
| Buy* | 2,400 | 1,918.00 | Ordinary Delayed publication | 17:38:38 - 20-Sep-19 |
| Buy* | 1,733 | 1,916.887 | Ordinary | 17:58:51 - 20-Sep-19 |
| Buy* | 2,818 | 1,916.887 | Ordinary | 17:50:20 - 20-Sep-19 |
| Buy* | 3,144 | 1,916.888 | Ordinary | 17:49:48 - 20-Sep-19 |
| Buy* | 1,848 | 1,918.00 | Ordinary | 17:45:54 - 20-Sep-19 |
| Buy* | 27,332 | 1,917.689 | Ordinary | 17:45:16 - 20-Sep-19 |
| Sell* | 122,732 | 1,915.775 | Ordinary | 17:44:58 - 20-Sep-19 |
| Sell* | 2,657 | 1,915.097 | Ordinary | 17:44:15 - 20-Sep-19 |
Share Price History for Smith & Nephew |
|||||
| Date | Open | High | Low | Close | |
|---|---|---|---|---|---|
| 18th Sep 2019 (Wed) | 1,919.00 | 1,929.00 | 1,903.00 | 1,910.00 | |
| 17th Sep 2019 (Tue) | 1,875.50 | 1,915.50 | 1,871.50 | 1,904.50 | |
| 16th Sep 2019 (Mon) | 1,874.50 | 1,896.00 | 1,870.00 | 1,883.75 | |
| 13th Sep 2019 (Fri) | 1,898.00 | 1,901.00 | 1,864.50 | 1,889.50 | |
| 12th Sep 2019 (Thu) | 1,902.50 | 1,920.50 | 1,884.00 | 1,911.25 | |
| 11th Sep 2019 (Wed) | 1,885.00 | 1,899.00 | 1,863.50 | 1,895.50 | |
| 10th Sep 2019 (Tue) | 1,920.00 | 1,924.50 | 1,856.50 | 1,882.25 | |
| 9th Sep 2019 (Mon) | 1,979.50 | 1,980.00 | 1,920.50 | 1,933.00 | |
| 6th Sep 2019 (Fri) | 1,956.00 | 1,978.00 | 1,947.50 | 1,974.25 | |
| 5th Sep 2019 (Thu) | 1,985.00 | 1,985.00 | 1,938.00 | 1,944.00 | |
| 4th Sep 2019 (Wed) | 1,978.00 | 1,992.50 | 1,969.00 | 1,976.75 | |
| 3rd Sep 2019 (Tue) | 1,993.50 | 1,998.00 | 1,979.00 | 1,982.50 | |
| 2nd Sep 2019 (Mon) | 1,969.00 | 1,998.00 | 1,965.00 | 1,988.00 | |
| 30th Aug 2019 (Fri) | 1,974.50 | 1,974.50 | 1,954.00 | 1,958.50 | |
| 29th Aug 2019 (Thu) | 1,968.50 | 1,981.00 | 1,957.50 | 1,976.00 | |
| 28th Aug 2019 (Wed) | 1,955.50 | 1,978.00 | 1,931.00 | 1,976.00 | |
| 27th Aug 2019 (Tue) | 1,923.50 | 1,937.50 | 1,901.50 | 1,931.75 | |
| 26th Aug 2019 (Mon) | 0 | 0.00 | 0.00 | 1,935.00 | |
| 23rd Aug 2019 (Fri) | 1,936.00 | 1,957.00 | 1,933.00 | 1,929.00 | |
| 22nd Aug 2019 (Thu) | 1,945.50 | 1,947.50 | 1,922.00 | 1,929.00 | |
| 21st Aug 2019 (Wed) | 1,913.50 | 1,945.00 | 1,912.50 | 1,939.25 | |
Smith & Nephew are presently the UK's largest medical technology company and one of global significance in its specialised field. Established over 150 years ago, the company now operates in over 30 countries worldwide, with their headquarters still being in London, UK. Their main focus revolves around developing and promoting novel products to help physicians treat aging patients with endoscopy techniques, orthopaedic reconstruction, trauma and advanced wound management being at the forefront of their research. The company feel that the increasingly aging population equals a significant growth potential for the already established markets of orthopaedics, endoscopy and wound management around the world.
Today, Smith & Nephew have over 1000 products in their arsenal and generate worldwide sales of over 3.4 billion dollars. They further report that over the last 5 years their revenues have grown from around nineteen hundred million dollars to over thirty three hundred million dollars – a percentage increase of nearly 100%. This success has been helped along by the launch of a new range of ingenious wound dressing products in 2008 and the acquisition of the Swiss company Plus Orthopaedics Holdings AG in 2007. Smith & Nephew research, develop and manufacture a number of new orthopaedic and wound management products each year, many of which quickly become established products within the UK and the US. The share price of this major medtech company has stayed stable for a number of years and continues to rise as new products are launched.
News - Thursday, December 30, 2010
The FTSE 100 index dropped by 0.2 per cent, a fall of just over 14 points by 11.41 GMT, creeping back under the 6000 mark to 5994. The banks suffered a poor morning of trading, but the miners strengthened despite the interest rate rise seen in China....
News - Thursday, April 08, 2010
Today started with big losses amongst mining stocks with these continuing on a downward trend in the afternoon. Stocks including Xstrata, down 3.84 per cent and Eurasian Natural Resources, down 3.20 per cent pushed the FTSE down. Gaining 2.85 per cent, British Airways' strong performance failed to offset losses. The FTSE 100 index closed at 5,712.70, down by 0.86 per cent or 49.36 points....
